Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07675330
NA

Oxymetazoline Versus Sodium Hypochlorite as Hemostatic Agents in MTA Pulpotomy of Primary Molars

Sponsor: Cairo University

View on ClinicalTrials.gov

Summary

This study aims to evaluate clinical and radiographic success of oxymetazoline versus sodium hypochlorite as hemostatic agents in MTA pulpotomy of primary molars.

Official title: Comparative Evaluation of Clinical and Radiographic Success of Oxymetazoline Versus Sodium Hypochlorite as Hemostatic Agents in MTA Pulpotomy of Primary Molars in a Group of Egyptian Children: A Randomized Controlled Trial

Key Details

Gender

All

Age Range

4 Years - 8 Years

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2026-08

Completion Date

2027-12

Last Updated

2026-06-30

Healthy Volunteers

No

Interventions

OTHER

Oxymetazoline 0.05% nasal solution

Using 1 drop (\~0.05 mL) of 0.05% OXY (Normifrin Nasal spray, MUP, Egypt, and generic equivalents) delivered through a micro- brush or a small cotton pellet over pulp stumps to achieve hemostasis.

OTHER

Sodium Hypochlorite Solution

Compression of a sterile cotton pellet soaked in 5% NaOCl over the pulpal stumps for 5 min

Locations (1)

Faculty of dentistry, Cairo University.

Cairo, Egypt